FDA Approves Rasonque for Advanced Pancreatic Cancer: What Patients and Families Should Know
The new once-daily pill nearly doubled median survival in a major trial. ... more
The new once-daily pill nearly doubled median survival in a major trial. ... more
A major international study found that adding apalutamide to hormone therapy before ... more
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Connect with us